Skip to content

Article: NAD+ Biosynthesis Enzyme Protects Aortic Smooth Muscle Cells: Preclinical Findings

NAD+ Biosynthesis Enzyme Protects Aortic Smooth Muscle Cells: Preclinical Findings


Synopsis

The walls of the aorta weaken with age and stress, risking serious damage. Smooth muscle cells (SMCs) in the aorta need NAD+, made by the enzyme NAMPT, for health. In humans with aortic disease, lower NAMPT in SMCs correlated with larger aortic size. Mice lacking NAMPT in SMCs had less NAD+, mild aortic dilation, and were prone to aortic injury from stress. These cells showed DNA damage and signs of early aging, which improved when NAD+ was restored using nicotinamide riboside. In diseased human aortas, low NAMPT was linked to DNA damage and gene silencing by DNA methylation. This suggests that maintaining NAD+ production in SMCs protects against DNA damage and premature aging of the aorta.

Journal

Circulation Research

Read more

Neurological Health

SARM1 Enzyme Drives Axonal NAD+ Loss and Degeneration: Preclinical Findings

Synopsis Axonal degeneration, or the breakdown of nerve fibers, happens early in many neurological diseases. The protein SARM1 is a key driver of this process, causing axons to lose NAD+, a vital ...

Read more
Cancer

Nicotinamide Riboside Decreased DNA Damage in Liver Cells: Preclinical Findings

Synopsis Hepatocellular carcinoma (HCC) is a fast-growing liver cancer, but its exact origin has been unclear. Using human data and mouse models, researchers found that HCC starts mainly from live...

Read more